LEADER 01852nam  2200433 a 450 
001 9910699069003321
005 20090813112543.0
035   $a(CKB)5470000002399194
035   $a(OCoLC)430340142
035   $a(EXLCZ)995470000002399194
100   $a20090813d2009      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedical devices$b[electronic resource] $eshortcomings in FDA's premarket review, postmarket surveillance, and inspections of device manufacturing establishments : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives /$fstatement of Marcia Crosse
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2009]
215   $a1 online resource (18 pages) $cillustrations
225 1 $aTestimony ;$vGAO-09-370T
300   $aTitle from title screen (GAO, viewed July 22, 2009).
300   $a"For release ... June 18, 2009."
320   $aIncludes bibliographical references.
517   $aMedical devices 
606   $aMedical instruments and apparatus industry$zUnited States
606   $aMedical instruments and apparatus$xInspection$zUnited States
606   $aRisk assessment$xGovernment policy$zUnited States
615  0$aMedical instruments and apparatus industry
615  0$aMedical instruments and apparatus$xInspection
615  0$aRisk assessment$xGovernment policy
700   $aCrosse$b Marcia$01380679
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.$bSubcommittee on Health.
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699069003321
996   $aMedical devices$93495374
997   $aUNINA